Protocol summary

Study aim
Determining the effectiveness of electromagnetism in the magnet device in improving pain and function of patients with second and third degree knee osteoarthritis.
Design
Clinical trial with control group, with parallel groups, single-blind, randomized, on 60 patients. Random Allocation version 2 software will be used for randomization.
Settings and conduct
This randomized study, with equal randomization with a simple sequence, a single-blind clinical trial, controlled with drug therapy, a parallel group study, on patients with second and third degree OA referring to the physical medicine and rehabilitation clinic of the university Isfahan Medical Sciences. Blinding will be done by the method of 2 replacement blocks of sampling. Blinding will be done for the person who collects the data and the person who performs the data analysis. Due to the nature of the study, there is no possibility of blinding the patients.
Participants/Inclusion and exclusion criteria
Inclusion criteria: 2nd and 3rd degree OA diagnosis, age ≥40 years, daily symptoms since 6 months ago, pain with VAS ≥3 criteria. Exclusion criteria: intra-articular drug administration, systemic treatment with corticosteroids, knee pain due to malignant pathology, autoimmune and inflammation, history of knee surgery, pregnancy, metal implant
Intervention groups
Group A: Drug treatment with 1 tablet of meloxicam 15 mg once a day for 18 days and exercise therapy 3 times a day for 18 days, each for 20 seconds and 3 times each time. The magnet device is turned off for The patient is placed. Group B: PEMF treatment in this group is performed in addition to drug treatment and exercise using a magnet device. The number of sessions is 8 sessions, 3 times a week. The time of each session is 30 minutes.
Main outcome variables
Reducing knee osteoarthritis symptoms

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20231007059642N1
Registration date: 2023-10-22, 1402/07/30
Registration timing: prospective

Last update: 2023-10-22, 1402/07/30
Update count: 0
Registration date
2023-10-22, 1402/07/30
Registrant information
Name
Saeideh Safinataj
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 913 347 5411
Email address
saeide.safi@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-10-23, 1402/08/01
Expected recruitment end date
2025-10-23, 1404/08/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Investigating the effectiveness of electromagnetic therapy on improving the symptoms of second and third degree knee osteoarthritis
Public title
Investigating the effect of electromagnetism in reducing knee osteoarthritis symptoms
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Primary diagnosis of grade 2 and 3 OA based on ACR criteria, including radiological evidence, clinical examination and history Age ≥40 years The presence of dry knee symptoms and frequent daily pain since 6 months ago Symptomatic illness from at least 6 months ago Presence of pain with VAS ≥3 criteria
Exclusion criteria:
Intra-articular drug administration in the last 6 months Systemic treatment with corticosteroids or physical therapy in the last 6 weeks Cartilaginous consumption in the last 6 weeks Back radicular pains Knee pain caused by malignant, autoimmune and inflammatory pathology or caused by knee deformities such as genovarus and genovalgus etc. Patients who have a history of knee surgery Lack of cooperation and difficulty in referring and following the intervention process pregnancy Metal implant like heart pacemaker
Age
From 40 years old to 70 years old
Gender
Both
Phase
N/A
Groups that have been masked
  • Care provider
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
A simple randomization method is used. Sampling will be done by the method of alternating blocks of 2 in such a way that we will have 10 blocks of 3 and each block will contain 3 letters from the letters A and B, including AAB-ABA-BBA-BAB and..... (two groups of 30 Each patient is randomly given a card, the cards are in sealed envelopes, and the technician takes the envelopes in order and delivers them to the patients.
Blinding (investigator's opinion)
Single blinded
Blinding description
Random Allocation version 2 software will be used. Sampling will be done by the method of 2 permutation blocks in such a way that we will have 10 blocks of 4 and each block contains 4 letters from letters A and B including AABB-ABAB-BBAA-BABA and..... (two groups of 40) one card for each patient randomly It is given that the cards are in sealed envelopes and the technician takes the envelopes in order and delivers them to the patients. Due to the nature of the study, it is not possible to blind the patients. The person who collects the data does not know whether the data belongs to group A or group B. The person who analyzes the data does not know whether he belongs to group A or group B.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethical Committee of Isfahan University of Medical Sciences, Faculty of Medicine
Street address
Unit 5, Hafez Building, 4th dead end on the right, 28 Yavar Alley, Barazandeh Street
City
Isfahan
Province
Isfehan
Postal code
8193967748
Approval date
2023-10-03, 1402/07/11
Ethics committee reference number
IR.MUI.MED.REC.1402.242

Health conditions studied

1

Description of health condition studied
Knee osteoarthritis
ICD-10 code
M17
ICD-10 code description
Osteoarthritis of knee

Primary outcomes

1

Description
Symptoms of knee osteoarthritis
Timepoint
before, immediately and 6 weeks and 3 months after the end of the treatment
Method of measurement
Visual Analogue Scale and Western Ontario and McMaster Universities Osteoarthritis Index scale

Secondary outcomes

1

Description
Average pain intensity
Timepoint
Before, immediately and 6 weeks and 3 months after the end of the treatment
Method of measurement
Visual Analogue Scale

2

Description
Physical performance
Timepoint
Before, immediately and 6 weeks and 3 months after the end of the treatment
Method of measurement
Western Ontario and McMaster Universities Osteoarthritis Index

3

Description
Joint dryness
Timepoint
Before, immediately and 6 weeks and 3 months after the end of the treatment
Method of measurement
Western Ontario and McMaster Universities Osteoarthritis Index

4

Description
Range of motion
Timepoint
Before, immediately and 6 weeks and 3 months after the end of the treatment
Method of measurement
Western Ontario and McMaster Universities Osteoarthritis Index

Intervention groups

1

Description
Intervention group: In this group, drug treatment with 1 tablet of meloxicam 15mg once a day for 18 days and exercise therapy 3 times a day for 18 days, each for 20 seconds and 3 times each time.Sports include the following:Stretching of quadriceps and calf muscle, strengthening of quadriceps and hamesteringIn addition to drug therapy and exercise, the group is performed using the magno 915G device, made in Iran, located in the physical medicine and rehabilitation department of Amin Hospital. The number of PEMF sessions is 8 sessions, 3 times a week. The patient is in a supine position. The back (SUPINE) is placed on the bed. Then the entire knee area will be placed under the electromagnet device. The total treatment time per session is 30 minutes.
Category
Treatment - Devices

2

Description
Control group:In this group, drug treatment with 1 tablet of meloxicam 15mg once a day for 18 days and exercise therapy 3 times a day for 18 days, each for 20 seconds and 3 times each time.Sports include the following:Stretching of quadriceps and calf muscle, strengthening of quadriceps and hamesteringIn this group, the magnet device is turned off for the patient.
Category
Treatment - Devices

Recruitment centers

1

Recruitment center
Name of recruitment center
Amin Hospital
Full name of responsible person
Saeideh Safinataj
Street address
Amin Medical Education Center,Sanbulistan Street, Sina Steet, Shahada Square
City
Isfahan
Province
Isfehan
Postal code
8148653141
Phone
+98 31 3112 2020
Email
saeide.safi@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Gholam Reza Askari
Street address
Research and Technology Vice-Chancellor, Building No. 4,Isfahan University of Medical Sciences and Health Care Services,Hazar Jarib Street
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3792 3060
Email
askari@mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Saeideh Safinataj
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
Unit 5, Hafez Building, 4th dead end on the right, 28 Yavar Alley,Barazande Street
City
Isfahan
Province
Isfehan
Postal code
8193967748
Phone
+98 913 347 5411
Email
saeide.safi@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Saeideh Safinataj
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
Unit 5,hafez building,Right side of the 4th deadend,Yavar 28 alley,Barazandeh street
City
Esfahan
Province
Isfehan
Postal code
8193967748
Phone
+98 913 347 5411
Fax
Email
saeide.safi@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Saeideh Safinataj
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Physical Medicine
Street address
Unit 5,hafez building,Right side of the 4th deadend,Yavar 28 alley,Barazandeh street
City
Esfahan
Province
Isfehan
Postal code
8193967748
Phone
+98 913 347 5411
Fax
Email
saeide.safi@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...